14
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Scleroderma after Therapy with Appetite Suppressants: Report on Four Cases

, &
Pages 87-90 | Received 03 May 1989, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mahdi Balali-Mood, Rodney D. Sinclair, Emadodin Darchini-Maragheh & Leila Etemad. (2023) Mucocutaneous alterations and complications in amphetamine abusers: a narrative review. Cutaneous and Ocular Toxicology 42:4, pages 219-231.
Read now

Articles from other publishers (29)

Yasuhito Hamaguchi. (2022) Drug-induced scleroderma-like lesion. Allergology International 71:2, pages 163-168.
Crossref
Véronique Debien, Arthur Petitdemange, Dorothée Bazin, Carole Ederle, Benoit Nespola, Hamid Merdji, Jérome Olagne, Thierry Martin, Aurélien Guffroy & Carole Pflumio. (2021) New-onset systemic sclerosis and scleroderma renal crisis under docetaxel. Journal of Scleroderma and Related Disorders 6:3, pages 306-310.
Crossref
R. Garnier, C. Médernach, H. Laborde-Castérot & J. Langrand. (2021) Sclérodermie et exposition professionnelle aux solvants organiques. Revue de la littérature et méta-analyse. Toxicologie Analytique et Clinique 33:3, pages 193-210.
Crossref
Alicia Rodriguez-Pla & Robert W Simms. (2019) Geographic disparity in systemic sclerosis mortality in the United States: 1999–2017. Journal of Scleroderma and Related Disorders 6:2, pages 139-145.
Crossref
Lydia Ouchene, Anastasiya Muntyanu, Jérôme Lavoué, Murray Baron, Ivan V. Litvinov & Elena Netchiporouk. (2020) Toward Understanding of Environmental Risk Factors in Systemic Sclerosis. Journal of Cutaneous Medicine and Surgery 25:2, pages 188-204.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 263 275 .
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 308 323 .
M Lidar, N Agmon-Levin, P Langevitz & Y Shoenfeld. (2012) Silicone and scleroderma revisited. Lupus 21:2, pages 121-127.
Crossref
N. Hatton, T. Frech, B. Smith, A. Sawitzke, M. B. Scholand & B. Markewitz. (2011) Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis. International Journal of Clinical Practice 65, pages 35-43.
Crossref
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology 631 761 .
GABRIELA FERNANDA MORA. (2009) Systemic Sclerosis: Environmental Factors. The Journal of Rheumatology 36:11, pages 2383-2396.
Crossref
Pieter A. Cohen. (2008) Imported Fenproporex-based Diet Pills from Brazil: A Report of Two Cases. Journal of General Internal Medicine 24:3, pages 430-433.
Crossref
. 2009. Meyler's Side Effects of Psychiatric Drugs. Meyler's Side Effects of Psychiatric Drugs 451 628 .
R. Garnier, A. Bazire & D. Chataigner. (2006) Sclérodermie et exposition professionnelle aux solvants organiques. Archives des Maladies Professionnelles et de l'Environnement 67:3, pages 488-504.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 180 192 .
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 1333 1344 .
H. Englert, J. Joyner, R. Bade, M. Thompson, D. Morris, P. Chambers, G. Carroll & N. Manolios. (2005) Systemic scleroderma: a spatiotemporal clustering. Internal Medicine Journal 35:4, pages 228-233.
Crossref
Bruno Fautrel & Pierre Bourgeois. (2002) Sclérodermies induites par des médicaments. Revue du Rhumatisme 69:4, pages 376-385.
Crossref
Reginald P. Sequeira. 2001. 1 11 .
H. Bröll, W. Graninger, B. Leeb, U. Stuby, W. Gebhart, O. Zamani & W. Siegmeth. 2001. Praktische Rheumatologie. Praktische Rheumatologie 405 421 .
Michael J. Landzberg, Drucilla J. Roberts & Eugene J. Mark. (1999) Case 4-1999. New England Journal of Medicine 340:6, pages 455-464.
Crossref
Andreas Beyer & Dieter Eis. 1999. Praktische Umweltmedizin. Praktische Umweltmedizin 41 122 .
Uwe-Frithjof HausteinMDMD & Bettina HauptMDMD. (1998) Drug-Induced Scleroderma and Sclerodermiform Conditions. Clinics in Dermatology 16:3, pages 353-366.
Crossref
O Hallé, T Schaeverbeke, B Bannwarth & J Dehais. (1997) Les facteurs d'environnement et les éléments iatrogènes dans la sclérodermie systémique et les syndromes apparentés. Revue de la littérature. La Revue de Médecine Interne 18:3, pages 219-229.
Crossref
Alan J. Silman & Marc C. Hochberg. (1996) OCCUPATIONAL AND ENVIRONMENTAL INFLUENCES ON SCLERODERMA. Rheumatic Disease Clinics of North America 22:4, pages 737-749.
Crossref
Reginald P. Sequeira. 1992. 1 6 .
A J Silman. (1991) Epidemiology of scleroderma.. Annals of the Rheumatic Diseases 50:Supplement 4, pages 846-853.
Crossref
Pierre Bourgeois & André Aeschlimann. (1991) Drug-induced scleroderma. Baillière's Clinical Rheumatology 5:1, pages 13-20.
Crossref
R. A. Asherson, R. Cervera, D. P. D'Cruz & G. R. Hughes. (1991) Rheumatology.. Postgraduate Medical Journal 67:784, pages 114-139.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.